Fiera Capital Corp Has $19.10 Million Stake in Option Care Health, Inc. (NASDAQ:OPCH)

Fiera Capital Corp boosted its stake in shares of Option Care Health, Inc. (NASDAQ:OPCH) by 1.1% in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 689,453 shares of the company’s stock after acquiring an additional 7,558 shares during the quarter. Fiera Capital Corp owned 0.40% of Option Care Health worth $19,098,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors also recently made changes to their positions in the stock. Rhumbline Advisers grew its stake in Option Care Health by 4.9% during the second quarter. Rhumbline Advisers now owns 572,665 shares of the company’s stock worth $15,863,000 after buying an additional 26,989 shares during the last quarter. Versor Investments LP bought a new position in Option Care Health in the 2nd quarter valued at $330,000. Nilsine Partners LLC boosted its stake in Option Care Health by 2.8% in the second quarter. Nilsine Partners LLC now owns 83,203 shares of the company’s stock worth $2,305,000 after purchasing an additional 2,293 shares in the last quarter. Van ECK Associates Corp grew its holdings in shares of Option Care Health by 2.4% during the second quarter. Van ECK Associates Corp now owns 37,118 shares of the company’s stock worth $1,028,000 after purchasing an additional 863 shares during the last quarter. Finally, Fort Washington Investment Advisors Inc. OH acquired a new stake in shares of Option Care Health in the second quarter valued at $18,774,000. 98.05% of the stock is owned by institutional investors.

Analyst Ratings Changes

Several research firms have weighed in on OPCH. Barrington Research raised their price objective on shares of Option Care Health from $38.00 to $40.00 and gave the company an “outperform” rating in a research report on Thursday, August 1st. JMP Securities assumed coverage on shares of Option Care Health in a research report on Tuesday, July 16th. They issued an “outperform” rating and a $36.00 price objective for the company.

Option Care Health Trading Up 1.1 %

OPCH opened at $32.37 on Wednesday. The firm has a 50 day simple moving average of $30.06 and a 200 day simple moving average of $30.50. Option Care Health, Inc. has a fifty-two week low of $26.11 and a fifty-two week high of $35.24. The company has a market cap of $5.54 billion, a price-to-earnings ratio of 21.30, a price-to-earnings-growth ratio of 2.43 and a beta of 1.24. The company has a debt-to-equity ratio of 0.78, a current ratio of 1.76 and a quick ratio of 1.36.

Option Care Health (NASDAQ:OPCH) last issued its earnings results on Wednesday, July 31st. The company reported $0.30 EPS for the quarter, beating the consensus estimate of $0.27 by $0.03. Option Care Health had a net margin of 4.60% and a return on equity of 14.82%. The company had revenue of $1.23 billion during the quarter, compared to analysts’ expectations of $1.17 billion. During the same quarter in the previous year, the company posted $0.63 EPS. The business’s revenue for the quarter was up 14.8% compared to the same quarter last year. On average, sell-side analysts anticipate that Option Care Health, Inc. will post 1.22 earnings per share for the current year.

Insider Transactions at Option Care Health

In related news, Director Elizabeth Quadros Betten sold 47,531 shares of the stock in a transaction that occurred on Wednesday, August 21st. The shares were sold at an average price of $31.09, for a total value of $1,477,738.79. Following the sale, the director now directly owns 21,339 shares in the company, valued at approximately $663,429.51. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. In other Option Care Health news, Director Elizabeth Quadros Betten sold 47,531 shares of Option Care Health stock in a transaction dated Wednesday, August 21st. The stock was sold at an average price of $31.09, for a total transaction of $1,477,738.79. Following the transaction, the director now directly owns 21,339 shares in the company, valued at $663,429.51. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, CFO Michael H. Shapiro sold 23,217 shares of the business’s stock in a transaction dated Thursday, August 22nd. The shares were sold at an average price of $30.95, for a total value of $718,566.15. Following the completion of the transaction, the chief financial officer now directly owns 247,317 shares of the company’s stock, valued at $7,654,461.15. The disclosure for this sale can be found here. Corporate insiders own 0.64% of the company’s stock.

Option Care Health Company Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.